159 related articles for article (PubMed ID: 33154286)
1. P57
Awosusi BL; Ajani MA; Adegoke OO; Salami AA; Okolo CA
Niger Postgrad Med J; 2020; 27(4):331-335. PubMed ID: 33154286
[TBL] [Abstract][Full Text] [Related]
2. Determination of morphologic and immunohistochemical stain (p57
Oranratanaphan S; Khongthip Y; Areeruk W; Triratanachat S; Tantbirojn P; Phupong V; Vongpaisarnsin K; Lertkhachonsuk R
Taiwan J Obstet Gynecol; 2020 Jul; 59(4):570-574. PubMed ID: 32653131
[TBL] [Abstract][Full Text] [Related]
3. Challenges in the Routine Praxis Diagnosis of Hydatidiform Mole: a Tertiary Health Center Experience.
Lelic M; Fatusic Z; Iljazovic E; Ramic S; Markovic S; Alicelebic S
Med Arch; 2017 Aug; 71(4):256-260. PubMed ID: 28974845
[TBL] [Abstract][Full Text] [Related]
4. [Roles of p57KIP2 immunohistochemistry and flow cytometry in diagnosis of molar pregnancy].
Yang SM; You JF; Zhang XW; Zheng J; Liao SL
Zhonghua Bing Li Xue Za Zhi; 2009 Sep; 38(9):580-4. PubMed ID: 20079184
[TBL] [Abstract][Full Text] [Related]
5. The usefulness of p57(KIP2) immunohistochemical staining and genotyping test in the diagnosis of the hydatidiform mole.
Landolsi H; Missaoui N; Brahem S; Hmissa S; Gribaa M; Yacoubi MT
Pathol Res Pract; 2011 Aug; 207(8):498-504. PubMed ID: 21767919
[TBL] [Abstract][Full Text] [Related]
6. Recurrent Androgenetic Complete Hydatidiform Moles with p57
Li MW; Li F; Cheng J; Wang F; Zhou P
Reprod Sci; 2022 Jun; 29(6):1749-1755. PubMed ID: 34606065
[TBL] [Abstract][Full Text] [Related]
7. Accuracy of p57
Madi JM; Braga AR; Paganella MP; Litvin IE; Da Ros Wendland EM
Syst Rev; 2016 Oct; 5(1):169. PubMed ID: 27716354
[TBL] [Abstract][Full Text] [Related]
8. Complementary role of p57kip2 immunostaining in diagnosing hydatidiform mole subtypes.
Zainal N; Kampan NC; Rose IM; Ghazali R; Shafiee MN; Yussoff NH; Tamil A; Jamil MA; Hussin NH
Horm Mol Biol Clin Investig; 2021 May; 42(3):311-316. PubMed ID: 34018382
[TBL] [Abstract][Full Text] [Related]
9. A clinico-pathological study of complete and partial hydatidiform moles in a Nigerian population.
Osamor JO; Oluwasola AO; Adewole IF
J Obstet Gynaecol; 2002 Jul; 22(4):423-5. PubMed ID: 12521470
[TBL] [Abstract][Full Text] [Related]
10. Diagnosis and subclassification of hydatidiform moles using p57 immunohistochemistry and molecular genotyping: validation and prospective analysis in routine and consultation practice settings with development of an algorithmic approach.
McConnell TG; Murphy KM; Hafez M; Vang R; Ronnett BM
Am J Surg Pathol; 2009 Jun; 33(6):805-17. PubMed ID: 19145201
[TBL] [Abstract][Full Text] [Related]
11. "While there is p57, there is hope." The past and the present of diagnosis in first trimester abortions: Diagnostic dilemmas and algorithmic approaches. A review.
Giacometti C; Bellan E; Ambrosi A; Dei Tos AP; Cassaro M; Ludwig K
Placenta; 2021 Dec; 116():31-37. PubMed ID: 33714612
[TBL] [Abstract][Full Text] [Related]
12. Multiplex short tandem repeat DNA analysis confirms the accuracy of p57(KIP2) immunostaining in the diagnosis of complete hydatidiform mole.
Popiolek DA; Yee H; Mittal K; Chiriboga L; Prinz MK; Caragine TA; Budimlija ZM
Hum Pathol; 2006 Nov; 37(11):1426-34. PubMed ID: 16949913
[TBL] [Abstract][Full Text] [Related]
13. Diagnostic reproducibility of hydatidiform moles: ancillary techniques (p57 immunohistochemistry and molecular genotyping) improve morphologic diagnosis.
Vang R; Gupta M; Wu LS; Yemelyanova AV; Kurman RJ; Murphy KM; Descipio C; Ronnett BM
Am J Surg Pathol; 2012 Mar; 36(3):443-53. PubMed ID: 22245958
[TBL] [Abstract][Full Text] [Related]
14. p57(KIP2) immunohistochemical staining of gestational trophoblastic tumours does not identify the type of the causative pregnancy.
Sebire NJ; Rees HC; Peston D; Seckl MJ; Newlands ES; Fisher RA
Histopathology; 2004 Aug; 45(2):135-41. PubMed ID: 15279631
[TBL] [Abstract][Full Text] [Related]
15. Role of P57KIP2 Immunohistochemical Expression in Histological Diagnosis of Hydatidiform Moles.
Triratanachat S; Nakaporntham P; Tantbirojn P; Shuangshoti S; Lertkhachonsuk R
Asian Pac J Cancer Prev; 2016; 17(4):2061-6. PubMed ID: 27221896
[TBL] [Abstract][Full Text] [Related]
16. [Clinical characteristics and diagnosis of early hydatidiform mole].
Jiao LZ; You SY; Wang YP; Zhu CG; Jiang JY
Zhonghua Fu Chan Ke Za Zhi; 2019 Nov; 54(11):756-762. PubMed ID: 31752459
[No Abstract] [Full Text] [Related]
17. Diagnosis of hydatidiform moles using p57 immunohistochemistry and HER2 fluorescent in situ hybridization.
LeGallo RD; Stelow EB; Ramirez NC; Atkins KA
Am J Clin Pathol; 2008 May; 129(5):749-55. PubMed ID: 18426735
[TBL] [Abstract][Full Text] [Related]
18. Accuracy of p57
Madi JM; Braga A; Paganella MP; Litvin IE; Wendland EM
BJOG; 2018 Sep; 125(10):1226-1233. PubMed ID: 29782064
[TBL] [Abstract][Full Text] [Related]
19. Characterization of androgenetic/biparental mosaic/chimeric conceptions, including those with a molar component: morphology, p57 immnohistochemistry, molecular genotyping, and risk of persistent gestational trophoblastic disease.
Lewis GH; DeScipio C; Murphy KM; Haley L; Beierl K; Mosier S; Tandy S; Cohen DS; Lytwyn A; Elit L; Vang R; Ronnett BM
Int J Gynecol Pathol; 2013 Mar; 32(2):199-214. PubMed ID: 23370656
[TBL] [Abstract][Full Text] [Related]
20. p57kip2 is useful in the classification and differential diagnosis of complete and partial hydatidiform moles.
Jun SY; Ro JY; Kim KR
Histopathology; 2003 Jul; 43(1):17-25. PubMed ID: 12823708
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
